Literature DB >> 11867919

Adverse drug reactions: mechanisms and assessment.

Johannes Ring1, Knut Brockow.   

Abstract

Adverse drug reactions (ADR) are an important clinical problem. They account for about 5% of all hospital admissions and cause death in approximately 0.01% of surgical patients. The mechanisms leading to ADR beyond IgE-mediated allergy are still poorly understood. The importance of chemically reactive drug metabolites and the involvement of T-lymphocytes in many drug hypersensitivity reactions have been highlighted in recent years. ADR are diagnosed on clinical grounds and the temporal relation between drug intake and the appearance of the symptoms. Allergy tests are required in the further assessment of the reaction. By means of skin tests, in vitro tests and provocation tests information about the culprit drug, the mechanism involved and possible alternatives can be obtained. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867919     DOI: 10.1159/000048905

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  4 in total

Review 1.  [Triggers of exanthematous drug eruptions: Stop intake, treat through or desensitization?]

Authors:  M Absmaier; T Biedermann; K Brockow
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

2.  PF4/heparin complexes are T cell-dependent antigens.

Authors:  Shayela Suvarna; Lubica Rauova; Emily K E McCracken; Christina M Goss; Bruce S Sachais; Steven E McKenzie; Michael P Reilly; Michael Dee Gunn; Douglas B Cines; Mortimer Poncz; Gowthami Arepally
Journal:  Blood       Date:  2005-04-21       Impact factor: 22.113

3.  Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions.

Authors:  Said Benahmed; Marie Christine Picot; Dominique Hillaire-Buys; Jean Pierre Blayac; Pierre Dujols; Pascal Demoly
Journal:  Eur J Clin Pharmacol       Date:  2005-07-15       Impact factor: 2.953

4.  [Immediate drug hypersensitivity. Epidemiology, clinical features, triggers and management].

Authors:  K Brockow
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.